Title: What nurses need to know about weight-loss drugs: An update on weight-loss drugs semaglutide (Wegovy) and tirzepatide (Mounjaro), and the alternatives available.
Authors: Amara, Pavan
Abstract: Weight-loss injections, such as Wegovy and Mounjaro, are gaining more attention as pharmacological ways to combat obesity. The UK government has even suggested they could help get some unemployed people back into work. Here’s what nurses need to know.
Subjects: WEIGHT loss; NATIONAL health services; GLUCAGON-like peptide-1 agonists; BODY mass index; CLINICAL trials; GASTROENTEROLOGY nursing; PHARMACY information services; ANTIOBESITY agents; MORBID obesity; GENERIC drug substitution; OBESITY
Publication: Mental Health Practice, 2025, Vol 28, Issue 1, p10
ISSN: 1465-8720
Publication type: Academic Journal
DOI: 10.7748/mhp.28.1.10.s4

What nurses need to know about weight-loss drugs: An update on weight-loss drugs semaglutide (Wegovy) and tirzepatide (Mounjaro), and the alternatives available.

Amara, Pavan